𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer

✍ Scribed by Alain Bergeron; Valérie Picard; Hélène LaRue; Francois Harel; Hélène Hovington; Louis Lacombe; Yves Fradet

Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
349 KB
Volume
125
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Cancer‐testis (CT) genes encode proteins that are ideal targets for cancer immunotherapy because of their restricted expression in normal tissues and frequent expression in cancers. We previously observed that MAGE‐A9 was one of the CT genes most frequently expressed in bladder tumors. To confirm that observation and evaluate the potential prognostic value of MAGE‐A9 protein, we analyzed its expression by immunohistochemistry in 493 primary bladder tumors and 33 lymph node metastases, in comparison with MAGE‐A4 protein, also frequently expressed in bladder tumors. Overall, MAGE‐A4 and MAGE‐A9 were observed, respectively, in 38% and 63% of nonmuscle‐invasive tumors, 48% and 57% of muscle‐invasive tumors, 65% and 84% of carcinomas in situ and in 73% and 85% of lymph node metastases. Expression was associated with higher grade (MAGE‐A4, p = 0.007; MAGE‐A9, p = 0.012). In multivariate Cox regression analyses, expression of MAGE‐A9 in pTa tumors was associated with recurrence (HR = 1.829; p = 0.010). In univariate analyses, MAGE‐A4 expression in these same tumors was associated with progression to muscle‐invasive cancer (HR = 7.417, p = 0.013). MAGE‐A9 expression was even more predictive of progression as all tumors that progressed expressed this antigen. In muscle‐invasive bladder tumors, no association was found between expression of either MAGE and bladder cancer‐specific death. In conclusion, MAGE‐A9 is a target of choice for bladder cancer immunotherapy as it is expressed in 60% of bladder tumors, predominantly high‐grade tumors, and at higher frequency in pTis and metastatic tumors. Moreover, in pTa tumors, an immunotherapy targeting MAGE‐A9 could be protective against recurrence and progression to more advanced cancer. © 2009 UICC

📜 SIMILAR VOLUMES

MAGE-A9 mRNA and protein expression in b
MAGE-A9 mRNA and protein expression in bladder cancer
✍ Valérie Picard; Alain Bergeron; Hélène LaRue; Yves Fradet 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 362 KB 👁 2 views

## Abstract In a previous analysis, we showed that MAGE‐As were the most frequently expressed cancer‐testis antigens in human bladder tumours. Here, we further characterized by RT‐PCR the expression of this family of genes by analyzing specifically MAGE‐A3, ‐A4, ‐A8 and ‐A9 mRNAs in 46 bladder tumo

Frequency of gallbladder cancer in chile
Frequency of gallbladder cancer in chile, A high-risk area
✍ Flavio Nervi; Ignacio Duarte; Guillermo Gómez; Germán Rodríguez; Guido Del Pino; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 423 KB 👁 1 views

We report an autopsy study of gallbladder cancer prevalence in Chile, where the risk of this disease is among the highest reported world-wide. In 14,768 autopsy protocols obtained from 3 university hospitals, 45% of women and 20% of men older than 20 years had gallstone disease (the major known risk

High expression of cancer testis antigen
High expression of cancer testis antigens MAGE-A, MAGE-C1/CT7, MAGE-C2/CT10, NY-ESO-1, and gage in advanced squamous cell carcinoma of the larynx
✍ David L. A. Figueiredo; Rui C. M. Mamede; Giulio C. Spagnoli; Wilson A. Silva Jr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 1 views

## Abstract ## __Background.__ Despite diagnostic and therapeutic advances in head and neck cancer, the 5‐year survival of patients with laryngeal cancer has not improved in the last 30 years. Several recent studies indicate that specific targets for immunotherapeutic approaches can be useful in t

Changing trends of gall-bladder cancer i
Changing trends of gall-bladder cancer in chile, a high-risk area
✍ Ivan Serra; Alfonso Calvo; Mauricio Maturana; Ernesto Medina; Allan Sharp 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 164 KB 👁 1 views

## Changing trends of gall-bladder cancer in Chile, a high-risk area An autopsy study of gall-bladder cancer in Chile has been published (Nervi et al., 1988). We have reported, based on mortality data (Armijo, 1979), and on clinical data which are consistent, that the incidence of gall-bladder can

Expression of mage-A4 and mage-C1 tumor-
Expression of mage-A4 and mage-C1 tumor-associated antigen in benign and malignant thyroid diseases
✍ Daniel Hardy Melo; Rui Celso Martins Mamede; Luciano Neder; Fabiano Pinto Saggio 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB 👁 1 views

## Abstract ## Background A subset of thyroid tumors characterized by a follicular growth pattern can represent a serious diagnosis. Immunohistochemistry and molecular pathology for genetic profiling have been used in an attempt to resolve some of these issues. ## Methods Tumor tissue samples of